Page last updated: 2024-11-08

24,25-oxidolanosterol

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

24,25-oxidolanosterol: OLAN is 24(S),25-oxidolanosterol [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID189047
SCHEMBL ID19199366
MeSH IDM0064639

Synonyms (10)

Synonym
olan
18303-41-8
(3s,10s,13r,14r,17r)-17-[(2r)-4-(3,3-dimethyloxiran-2-yl)butan-2-yl]-4,4,10,13,14-pentamethyl-2,3,5,6,7,11,12,15,16,17-decahydro-1h-cyclopenta[a]phenanthren-3-ol
24,25-oxidolanosterol
24(s),25-oxidolanosterol
lanost-8-en-3-ol, 24,25-epoxy-, (3beta)-
24,25-epoxylanosterol
SCHEMBL19199366
24,25-epoxylanost-8-en-3-ol
DTXSID50939674
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (7)

TimeframeStudies, This Drug (%)All Drugs %
pre-19905 (71.43)18.7374
1990's1 (14.29)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (14.29)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]